0178-3351
2015 Issue 2
Lung cancer: Progress, current status, and controversies
Yuan Chen;Department of Oncology;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;
Yuan Chen;Department of Oncology;Tongji Hospital;Tongji Medical College;Huazhong University of Science and Technology;
..............page:49-50
Role of radiation therapy in the management of stage Ⅲ non-small cell lung cancers: current status and controversies
Wen Feng;Xiaolong Fu;Department of Radiation Oncology;Fudan University Shanghai Cancer Center;Department of Oncology;Shanghai Medical College;Fudan University;Department of Radiation Oncology;Shanghai Chest Hospital;Shanghai Jiao Tong University;
Wen Feng;Xiaolong Fu;Department of Radiation Oncology;Fudan University Shanghai Cancer Center;Department of Oncology;Shanghai Medical College;Fudan University;Department of Radiation Oncology;Shanghai Chest Hospital;Shanghai Jiao Tong University;
..............page:51-57
Antiangiogenic agents combined with chemotherapy in non-small cell lung cancer
Shanshan Chen;Shun Lu;Shanghai Lung Cancer Center;Shanghai Chest Hospital;Shanghai Jiao Tong University;
Shanshan Chen;Shun Lu;Shanghai Lung Cancer Center;Shanghai Chest Hospital;Shanghai Jiao Tong University;
..............page:58-64
Influence of tumor response on the survival of patients with extensive-stage small-cell lung cancer treated with the etoposide plus cisplatin chemotherapy regimen
Guojing Zhang;Yongye Liu;Chao Lin;Jianfei Guo;Long Xu;Junling Liu;Ying Piao;Guanzhong Zhang;Yuhui Liu;Yaling Han;Xiaodong Xie;Department of Oncology;PLA Cancer Center;The General Hospital of Shenyang Military Region;Department of Gynaecology;The Wenzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University;Department of Cardiology;Institute of Cardiovascular Research of PLA;The General Hospital of Shenyang Military Region;
Guojing Zhang;Yongye Liu;Chao Lin;Jianfei Guo;Long Xu;Junling Liu;Ying Piao;Guanzhong Zhang;Yuhui Liu;Yaling Han;Xiaodong Xie;Department of Oncology;PLA Cancer Center;The General Hospital of Shenyang Military Region;Department of Gynaecology;The Wenzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University;Department of Cardiology;Institute of Cardiovascular Research of PLA;The General Hospital of Shenyang Military Region;
..............page:65-68
The influence of autologous cytokine-induced killer cell treatment on the objective efficacy and safety of gefitinib in advanced non-small cell lung cancer
Shuxian Qu;Zhaozhe Liu;Zhendong Zheng;Zhenyu Ding;Tao Han;Fang Guo;Jianing Qiu;Xiaodong Xie;Dongchu Ma;Oncology Department;General Hospital of Shenyang Military Region;
Shuxian Qu;Zhaozhe Liu;Zhendong Zheng;Zhenyu Ding;Tao Han;Fang Guo;Jianing Qiu;Xiaodong Xie;Dongchu Ma;Oncology Department;General Hospital of Shenyang Military Region;
..............page:69-72
Role of the STAT3/survivin signaling pathway in the EML4-ALK-positive lung adenocarcinoma cell line H2228 before and after crizotinib-induced resistance
Haiyan Peng;Wenhua Zhao;Cuiyun Su;Xiangqun Song;Aiping Zeng;Huilin Wang;Ruiling Ning;Shaozhang Zhou;Second Department of Chemotherapy;Affiliated Cancer Hospital;Guangxi Medical University;
Haiyan Peng;Wenhua Zhao;Cuiyun Su;Xiangqun Song;Aiping Zeng;Huilin Wang;Ruiling Ning;Shaozhang Zhou;Second Department of Chemotherapy;Affiliated Cancer Hospital;Guangxi Medical University;
..............page:73-77
Clinical observation of capecitabine monotherapy in elderly patients with advanced breast cancer
Miao Zhang;Zhaozhe Liu;Zhendong Zheng;Tao Han;Yaling Han;Min Song;Xiaodong Xie;Graduate school;Dalian Medical University;Oncology Department;General Hospital of Shenyang Military Region;
Miao Zhang;Zhaozhe Liu;Zhendong Zheng;Tao Han;Yaling Han;Min Song;Xiaodong Xie;Graduate school;Dalian Medical University;Oncology Department;General Hospital of Shenyang Military Region;
..............page:78-81
Vascular endothelial growth factor and microvessel density for detection and prognostic evaluation of invasive breast cancer
Lukui Yang;Long Li;Xiangyu Cui;Dalei Yang;Department of Health Care Center;Rizhao Entry-Exit Inspection and Quarantine Bureau;Department of General Surgery;The People’s Hospital of Rizhao City;Blood Collection Department;Rizhao Central Blood Station;
Lukui Yang;Long Li;Xiangyu Cui;Dalei Yang;Department of Health Care Center;Rizhao Entry-Exit Inspection and Quarantine Bureau;Department of General Surgery;The People’s Hospital of Rizhao City;Blood Collection Department;Rizhao Central Blood Station;
..............page:82-86
Jinlong capsule decreases adverse reactions after transcatheter arterial chemoembolization(TACE) in patients with hepatocellular carcinoma
Wukui Huang;Dengyao Liu;Lina You;Shufa Yang;Mo Liu;Peng Gu;Pingju Wang;Baikere Pahaerding;Xiwen Fan;Department of Intervention Radiology;The Affiliated Tumor Hospital of Xinjiang Medical University;Department of Traditional Chinese Medical;The Fifth Affiliated Hospital of Xinjiang Medical University;
Wukui Huang;Dengyao Liu;Lina You;Shufa Yang;Mo Liu;Peng Gu;Pingju Wang;Baikere Pahaerding;Xiwen Fan;Department of Intervention Radiology;The Affiliated Tumor Hospital of Xinjiang Medical University;Department of Traditional Chinese Medical;The Fifth Affiliated Hospital of Xinjiang Medical University;
..............page:87-91
MicroRNAs in tumor stem cells
Xiaochen Hu;Junqiang Yang;Ruijie Yang;Ruina Yang;Xinshuai Wang;Shegan Gao;Department of Oncology;Cancer Institute;the First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;
Xiaochen Hu;Junqiang Yang;Ruijie Yang;Ruina Yang;Xinshuai Wang;Shegan Gao;Department of Oncology;Cancer Institute;the First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;
..............page:92-96
..............page:97
..............page:98